Anniversary of GMP: change in the approach to the regulation of the pharmaceutical market (continued)
The second part of the article tells about the situation in the past in the pharmaceutical sector of industrial countries that led to the introduction of GMP; the viewpoints of the involved parties are described. The article also seeks to address the reasons of the fact that the national pharmaceutical industry is lagging behind other countries in transition to GMP.